January is Cervical Health Awareness Month, a reminder that more than 95% of cervical cancer cases are attributed to the human papillomavirus (HPV), according to the World Health Organization (WHO). HPV testing is a key segment of the double-digit, multi-billion-dollar global molecular diagnostic testing market, according to the new report The World Market for Molecular […]
One of the most explored applications of molecular diagnostics is oncology, a segment with sales exceeding $6 billion in 2023, according to new data published in Molecular Diagnostics in Oncology, Genetic/Inherited Diseases, and NIPT, 2023-2028, now on sale by leading medical and diagnostic market research firm Kalorama Information. In the report, the oncology segment is […]
Molecular point-of-care (mPOC) is a multi-billion dollar market with expanding international intrigue. Though the mPOC market is led by North America and Europe, the Asia-Pacific region makes up 10% of the market’s worldwide sales, with China positioned as a burgeoning power within the APAC. Kalorama Information, a leading medical market research firm, covers mPOC’s global […]
Future molecular IVD sales buoyed by COVID-19, infectious diseases, and sexually transmitted infections There is a market in excess of $21 billion for molecular testing technologies, reveals medical market research publisher Kalorama Information in The World Market for Molecular Diagnostics Tests, 11th Edition, a recent report added to the firm’s Knowledge Center subscription. The majority […]
